IRIS Registry analysis reveals anti-VEGF monotherapies are similarly effective in improving vision

The authors compared real-world visual acuity in neovascular AMD patients who were treated with a single anti–VEGF drug for 1 year.

https://www.aao.org/editors-choice/iris-registry-analysis-reveals-anti-vegf-monothera

Comments

Popular posts from this blog

I Spy a Stye in Your Eye

Post-LASIK Refraction and Pregnancy – Much Ado About Nothing?